CombiMatrix Q4 Revenues Climb 52 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix today reported that its fourth-quarter revenues rose 52 percent year over year.

For the three months ended Dec. 31, 2011, revenues totaled $1.2 million, compared to $804,000 a year ago as diagnostic services revenues, which comprised all of CombiMatrix's revenues in Q4 2011, increased 55 percent from $791,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

San Diego's biotech scene has a dearth of executives who are women, Stat News reports.

Some 90 percent of respondents to a Nature survey say there is a research reproducibility crisis.

In Genome Research this week: transcriptomic analysis of the Venus flytrap, SMASH approach for CNV analysis, and more.

A Caltech professor wins the Millennium Technology Prize that lauds technological advances that improve human life.